Try our Advanced Search for more refined results

J&J Beats $258M Risperdal Verdict In Split La. High Court

By Linda Chiem (January 28, 2014, 8:11 PM EST) -- A split Louisiana Supreme Court on Tuesday nixed a $258 million jury award against Johnson & Johnson unit Janssen Pharmaceuticals Inc. over its marketing of the antipsychotic drug Risperdal, finding that the state failed to prove the companies defrauded Louisiana's Medicaid program....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!